Benzinga | Aug 11, 2020 08:00AM EDT

Stifel Initiates Coverage On Renalytix AI with Buy Rating, Announces Price Target of $22

Stifel analyst Daniel Arias initiates coverage on Renalytix AI (NASDAQ:RNLX) with a Buy rating and announces Price Target of $22.